Aussies treated for their CLL - Paid Survey. P... - CLL Support

CLL Support

22,986 members39,473 posts

Aussies treated for their CLL - Paid Survey. Please help researchers explore treatment goals and provide opinions on treatment options

AussieNeil profile image
AussieNeilPartnerAdministrator
2 Replies

Currently, Australia is going through a generational change in CLL treatments with the move to targeted therapies. If you've had your CLL treated, your opinions on what worked well and what needs to improve, are sought after.

CaPPRE need at least 10 more Australian survey participants who have had treatment for their CLL and hence know what changes they would like to see.

Please contribute to ensuring the patient experience is considered, when funding choices for treatments and support services are made.

Visit survey.confirmit.com.au/wix... to check if you are eligible to participate in the 30-40 minute on-line survey. In appreciation for your time and contribution to the research, you will receive a payment of $70 for completion of the full survey. You will have the option of receiving a report of the findings. Participation is voluntary and you are free to withdraw at any time.

More information about CaPPRe and the surveys in this previous post: healthunlocked.com/cllsuppo...

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
2 Replies
AussieNeil profile image
AussieNeilPartnerAdministrator

Aussies who have had treatment for their CLL and are prepared to share how treatment should be improved, a reminder that this survey is still open! You'll be rewarded with a $70 gift card and a silimar donation will be given to CLL Support UK to support those newly diagnosed.

Neil

AussieNeil profile image
AussieNeilPartnerAdministrator

Can any Australians help? CAPPRE still require a few more surveys to complete their report.

Thanks,

Neil

Not what you're looking for?

You may also like...

NEW - Aussies with CLL - Your invitation to help researchers explore treatment goals and provide opinions on different treatment options

Further to last month's care and management survey, this month Community and Patient Preference...

Aussies and Kiwis with CLL - Your invitation to help researchers investigate what you value with respect to your care and management

Community and Patient Preference Research (CAPPRE), on behalf of a pharmaceutical company, is...

Please share experience of venetoclax plus obinutuzimab or acalabrutinib mono treatment in an important survey

Reminder - please complete the survey if you are any of the above treatments. At the moment we...

Aussies, please consider enrolling in this study into the personal impact of CLL and help our world wide CLL/SLL community

Australians diagnosed with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL),...

Your opportunity to support affordable access to Ibrutinib and Idelalisib for Aussies - Submissions close next Wed 7th October

Australia's November Pharmaceutical Benefits Advisory Committe (PBAC) meeting will consider listing...